InvestorsHub Logo
Followers 9
Posts 878
Boards Moderated 0
Alias Born 10/08/2015

Re: None

Monday, 07/20/2020 6:03:28 PM

Monday, July 20, 2020 6:03:28 PM

Post# of 463970
I really believe that anavex increased n by 30 more patients so that they could engage the fda because there are no approved and used medicines addressing this cns disease. They would not invest in these patients and also have to wait for their results for nothing. The delay in my opinion could be the company discussing the results with the fda. They must know if they are positive or not. This wait could very well pay off for us longs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News